Pathophysiology of essential hypertension: an update

被引:127
作者
Saxena, Tarun [1 ]
Ali, Azeema Ozefa [1 ]
Saxena, Manjari [2 ]
机构
[1] Mittal Hosp & Res Ctr, Dept Internal Med, Ajmer, India
[2] Mittal Hosp & Res Ctr, Dept Yoga & Phys Educ, Ajmer, India
关键词
Essential hypertension; nitric oxide; sympathetic overactivity; hypothalamus;
D O I
10.1080/14779072.2018.1540301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Hypertension is caused by increased cardiac output and/or increased peripheral resistance. Areas covered: The various mechanisms affecting cardiac output/peripheral resistance involved in the development of essential hypertension are covered. These include genetics; sympathetic nervous system overactivity; renal mechanisms: excess sodium intake and pressure natriuresis; vascular mechanisms: endothelial cell dysfunction and the nitric oxide pathway; hormonal mechanisms: the renin-angiotensin-aldosterone system (RAAS); obesity, obstructive sleep apnea (OSA); insulin resistance and metabolic syndrome; uric acid; vitamin D; gender differences; racial, ethnic, and environmental factors; increased left ventricular ejection force and hypertension and its association with increased basal sympathetic activity - cortical connections. Expert commentary: Maximum association of hypertension is found with sympathetic overactivity which is directly or indirectly involved in different mechanisms of hypertension including RAAS, OSA, obesity, etc.. It is not overt sympathetic activity but disturbed basal sympathetic tone. Basal sympathetic tone arises from hypothalamus; possibly affected by cortical influences. Therefore, hypertension is not merely a disease of circulatory system alone. Its pathogenesis involves alteration in ANS (autonomic nervous system) and likely in cortical-hypothalamic connections. Assessment of ANS and cortical-hypothalamic connections may be required for better understanding of hypertension.
引用
收藏
页码:879 / 887
页数:9
相关论文
共 59 条
[1]  
[Anonymous], 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P1
[2]  
[Anonymous], [No title captured]
[3]   Serum Uric Acid and Cardiometabolic Disease Another Brick in the Wall? [J].
Borghi, Claudio ;
Francesco, Arrigo ;
Cicero, Giuseppe .
HYPERTENSION, 2017, 69 (06) :1011-1013
[4]  
Borrell LN, 2011, ETHNIC DIS, V21, P429
[5]   Racism and Hypertension: A Review of the Empirical Evidence and Implications for Clinical Practice [J].
Brondolo, Elizabeth ;
Love, Erica E. ;
Pencille, Melissa ;
Schoenthaler, Antoinette ;
Ogedegbe, Gbenga .
AMERICAN JOURNAL OF HYPERTENSION, 2011, 24 (05) :518-529
[6]  
CHOBANIAN AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI DOI 10.1161/01.HYP.0000107251.49515.C2
[7]   Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance [J].
Cooper, Shawna A. ;
Whaley-Connell, Adam ;
Habibi, Javad ;
Wei, Yongzhong ;
Lastra, Guido ;
Manrique, Camila ;
Stas, Sameer ;
Sowers, James R. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 293 (04) :H2009-H2023
[8]   Salt and Sensitivity [J].
de Leeuw, Peter W. ;
Kroon, Abraham A. .
HYPERTENSION, 2013, 62 (03) :461-462
[9]   Endothelial function and dysfunction - Testing and clinical relevance [J].
Deanfield, John E. ;
Halcox, Julian P. ;
Rabelink, Ton J. .
CIRCULATION, 2007, 115 (10) :1285-1295
[10]   Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review [J].
Duprez, Daniel A. .
JOURNAL OF HYPERTENSION, 2006, 24 (06) :983-991